Business & Industry
Business & Industry
Novartis, SciNeuro Brain Shuttle Deal Expands Neuroscience
Novartis has entered into a licensing agreement with SciNeuro Pharmaceuticals focused on improving drug delivery to the brain. The Novartis and SciNeuro brain shuttle deal is valued at up to $1.7 billion and centers on an antibody-based program designed...
Business & Industry
UK Clinical Trial Regulatory Reforms Aim to Boost Research
A number of regulatory changes have been released by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to facilitate clinical research in the country. In order to expedite study approvals while maintaining patient safety, the UK clinical trial...
BioPharma
How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?
Asia-Pacific’s biotechnology landscape is not just growing it is transforming. In 2026, the region stands at a unique crossroads where scientific ambition meets real-world demands. This year will test the industry’s resilience, shape global health priorities, and redefine how...
Business & Industry
Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug
Teva Pharmaceutical Industries and Royalty Pharma have signed a funding agreement valued at up to $500 million to advance the development of TEV-408, an investigational therapy for autoimmune disorders, including vitiligo. The Teva, Royalty Pharma $500M deal would be...
Business & Industry
Revvity and Lilly Expand Lilly TuneLab Access via Signals
Revvity, Inc. announced a collaboration with Eli Lilly and Company to broaden access to Lilly TuneLab by bringing the platform to the Revvity Signals ecosystem. The collaboration builds on Revvity’s recently launched Signals Xynthetica offering and aims to accelerate...
Business & Industry
Daiichi Eyes Commercialization of its Leukemia Med Vanflyta
Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug across certain European countries.
This exclusive license, as well as the supply agreement goes on to...
Business & Industry
InduPro, Lilly Partner to Discover Novel Cancer Treatments
Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel cancer treatments through a pact that could as well be worth almost $950 million.
InduPro is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.